On May 7, 2025, the US District Court for the Northern District of Texas upheld the FDA decision to remove tirzepatide from the shortage list
Safety assessment should include screening for pancreatitis history, thyroid disease (especially personal or family medullary thyroid carcinoma), gallbladder disease, and severe kidney or liver impairment
Discussion This study involved clinical trials with GSH (yeast extract containing glutathione) that were conducted to evaluate its effectiveness in facilitating alcohol metabolism in the human body and alleviating symptoms associated with hangovers
When switching between two GLP-1 agonists, one should be aware of differences in pharmacology, like the drugs half-life, which allows varying administration schedules, for example, once daily with Victoza to once weekly with Ozempic
Stimulates growth factor production and cellular migration relevant to healing126